LifeVantage Strengthens Management Team with Appointment of Charles J. Wach as Chief Operating Officer
March 09 2017 - 9:00AM
LifeVantage Corporation (Nasdaq:LFVN), announced today the
appointment of Charles J. Wach as Chief Operating Officer,
effective March 13, 2017.
“We are pleased to have Charles ‘Chuck’ Wach join
the company as COO,” said LifeVantage President and Chief Executive
Officer, Darren Jensen. “He is an accomplished leader with
operations experience in the nutritional supplement, direct
selling, online retail, and global food and beverage industries.
His proven skills will help us to enhance our operations and
deliver shareholder value. Additionally, Chuck’s supply-chain
expertise and relationships with suppliers and manufacturers across
salient product categories will expand our sourcing and
manufacturing resources, broadening our supply chain and increasing
efficiencies.”
“I am genuinely honored and excited to join the
talented leaders at LifeVantage,” said Wach. “I look forward to
safeguarding and strategically expanding the company’s
well-curated, efficacious product portfolio. It is a true
privilege to join such an incredible company, and I’m confident
that my team and I will deliver new value to our distributors,
shareholders and LifeVantage itself.”
Mr. Wach brings more than 30 years of operations
and leadership experience, having served in multiple senior
operational roles with relevant industry experience. Most recently,
Mr. Wach served as Vice President of Operations and Supply Chain
Executive for Bodybuilding.com, Inc., a global internet specialty
retailer, from 2013 to 2017. Mr. Wach also served as Director of
Global Supply Chain, Materials Management for Nature’s Sunshine
Products, Inc. He has filled several operational roles for
Nestle-Perrier Group of America Inc., H.J. Heinz Co., and Frito
Lay, Inc. Mr. Wach received his Master of Business Administration
degree from Utah State University and his Bachelor of Science
degree in Finance from Brigham Young University.
About LifeVantage Corporation
LifeVantage Corporation (Nasdaq:LFVN), is a
science-based direct selling company dedicated to visionary science
that looks to transform health, wellness and anti-aging internally
and externally at the cellular level. The company is the maker of
Protandim ® Nrf2 and NRF1 Synergizers, its line of
scientifically-validated dietary supplements, the TrueScience®
Anti-Aging Skin Care Regimen, Canine Health®, the AXIO® energy
product line and the PhysIQ™ Smart Weight Management System.
LifeVantage was founded in 2003 and is headquartered in Salt Lake
City, Utah. www.lifevantage.com
Forward Looking Statements
This document contains forward-looking statements
made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Words and expressions
reflecting optimism, satisfaction or disappointment with current
prospects, as well as words such as "believe", "hopes", "intends",
"estimates", "expects", "projects", "plans", "anticipates", "look
forward to", "goal", "may be", "should", and variations thereof,
identify forward-looking statements, but their absence does not
mean that a statement is not forward-looking. Examples of
forward-looking statements include, but are not limited to,
statements we make regarding our leadership transition, future
growth, and shareholder value. Such forward-looking statements are
not guarantees of performance and the Company's actual results
could differ materially from those contained in such statements.
These forward-looking statements are based on the Company's current
expectations and beliefs concerning future events affecting the
Company and involve known and unknown risks and uncertainties that
may cause the Company's actual results or outcomes to be materially
different from those anticipated and discussed herein. These risks
and uncertainties include, among others, those discussed in greater
detail in the Company's Annual Report on Form 10-K and the
Company's Quarterly Report on Form 10-Q under the caption "Risk
Factors," and in other documents filed by the Company from time to
time with the Securities and Exchange Commission. The Company
cautions investors not to place undue reliance on the
forward-looking statements contained in this document. All
forward-looking statements are based on information currently
available to the Company on the date hereof, and the Company
undertakes no obligation to revise or update these forward-looking
statements to reflect events or circumstances after the date of
this document, except as required by law.
Investor Relations Contacts:
Cindy England
Director of Investor Relations
(801) 432-9036
investor@lifevantage.com
-or-
Scott Van Winkle
Managing Director, ICR
(617) 956-6736
scott.vanwinkle@icrinc.com
Lifevantage (NASDAQ:LFVN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Lifevantage (NASDAQ:LFVN)
Historical Stock Chart
From Apr 2023 to Apr 2024